Shannon Casey

Apr 13, 2024 | kevinmd.com | John Corsino |Terry Griffin |Robert Pearl |Shannon Casey

If it ain’t Boeing, I ain’t going—at one time, public opinion of an engineering company run by engineers. Today, perception is a little different. The multinational conglomerate and defense contractor owns some staggering recent mishaps—safety systems, door plugs, unclear technical issues. A disconnect between senior management and hands-on employees is reported. Analysts consider recent events symptoms of longer-standing organizational pathology, finally coming to light.

Apr 12, 2024 | kevinmd.com | Shannon Casey |Susan Levenstein |Robert Pearl |Eugene Chan

A splashy headline in The Washington Post caught my attention: “Breast cancer death rate dropped 58 percent over 44 years in U.S.” A Stanford Medicine news story reports that this victorious conclusion is based on “a new multicenter study led by Stanford Medicine clinicians and biomedical data scientists.” Using observational data, clinical trial data, and simulation modeling, the researchers found that approximately 25 percent of the reduction in breast cancer mortality was associated with...

Apr 1, 2024 | networthynews.com | Shannon Casey

Casey is a doctor assistant. Within the very first 5 minutes of comic Kevin James’ funny unique Irregardlesshe states a discussion he had with his physician throughout a regular visit. It went something like this:Physician: Whatever looks actually great. I do wish to let you understand however, you are prediabetic. James: [Chuckles] Who isn’t? James: Do I have diabetes? Physician: No.James: I could get diabetes? Medical professional: Yes.

Feb 4, 2024 | kevinmd.com | Akshat Jain |Lynn Marie Morski |John Corsino |Shannon Casey

In a significant leap forward for medical science, recent breakthroughs in gene therapy are ushering in a new era of treatment for various human diseases. The field of gene therapy, which involves manipulating or introducing genetic material into a person’s cells to treat or prevent disease, has seen remarkable advancements, with several gene therapy drugs receiving approval from the Food and Drug Administration (FDA).

Oct 29, 2023 | kevinmd.com | Shannon Casey |Sandra Vamos |Deanna Lernihan |Michael K. Gusmano

Subscribe to The Podcast by KevinMD. Catch up on old episodes!Join Ken Blaker, a health care and technology consultant, and Cuong Do, a health care executive, as they shed light on the latest developments in combating these challenging conditions. From the recent FDA approval of Leqembi to promising anti-neuroinflammation drugs and genetic approaches, we uncover the cutting-edge strategies that could change the future of Alzheimer’s care.